Grazziotin SA (CGRA3R) News

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

INVO Reports Record First Quarter 2024 Financial Results

SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the...

Form 8-K - Current report

Micro Cap Massively Bid Up Before Opening Bell

A Florida-based medical device company is finding tremendous success so far during Wednesday’s premarket after the company reported a...

INVO Reports Fourth Quarter and Full Year 2023 Financial Results

SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in...

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors

INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced...

Form S-4 - Registration of securities, business combinations

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Form 424B7 - Prospectus [Rule 424(b)(7)]